Definitive Contract 75F40120C00060

Toxicologic Pathology Associates Inc. was awarded a $20.7 million definitive contract by the Department of Health and Human Services' Food and Drug Administration to provide onsite pathology services from July 2015 through July 2020. The contract has a small business set aside designation. As part of its mission to protect public health, the FDA utilizes pathology expertise to evaluate samples for issues impacting medical products and the safety of the food supply. This award draws on the...

This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Experimental Pathology Laboratories, Inc. (EPL), a for-profit, employee-owned contract research organization. The contract, valued at $128,835.41, is for pathology support services and does not have a set-aside designation. EPL, which is registered in the System for Award Management (SAM) through January 2026, has extensive experience providing specialized...

The Department of Health and Human Services Food and Drug Administration (FDA) awarded a $21,248,120.84 definitive contract to Priority One Services, Inc., a minority-owned and self-certified small disadvantaged business, for on-site multi-center animal husbandry support services to the FDA's Animal Care and Use Programs (ACUP). This is a labor-hour contract to provide administrative support, animal care and oversight, and veterinary technical services for the FDA's animal research programs. The...

This federal contract award was issued by the Food and Drug Administration (FDA), a civilian agency, to Experimental Pathology Laboratories, Inc. (EPL), a for-profit, employee-owned contract research organization headquartered in Sterling, Virginia. The $461,566.87 firm fixed-price delivery order is for pathology support services and does not have a set-aside designation. EPL, which is registered in the System for Award Management (SAM) through January 2026, has established itself as a...

The Food and Drug Administration (FDA) awarded a $4,709,471.91 delivery order contract to Priority One Services, Inc., a minority-owned and self-certified small disadvantaged business. The contract is for veterinary technical support and animal care and vivarium management services for the FDA's White Oak Animal Program (WOAP) located in Silver Spring, Maryland. This contract is a task order under Priority One Services' existing $25 million indefinite-delivery, indefinite-quantity (IDIQ)...

The Food and Drug Administration (FDA) awarded a $91,630 firm-fixed-price purchase order contract to Discovery Life Sciences, LLC, a small disadvantaged business, for the delivery of 110 vials of primary cryopreserved human hepatocytes. This requirement supports the FDA's National Center of Toxicological Research (NCTR) Division of Biochemical Toxicology's research into drug toxicity and metabolic enzymes. The contract has a period of performance through August 19, 2024 and was awarded under a...

This is a $428,940.00 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Toxstrategies, LLC, a small business based in Austin, Texas. The primary purpose of the contract is to acquire a hazard and risk assessment protocol that requires special consideration for unique biological characteristics that may impact the evaluation of ingredients in cosmetic products. This contract has a total small business set-aside designation. Toxstrategies is a multidisciplinary...

This is a definitive contract awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to The Critical Path Institute (C-Path), a nonprofit organization, to provide services in support of the agency's Model-Informed Drug Development (MIDD) program for the evaluation and development of neurological drug products. The $1,128,848.00 firm fixed-price contract has an anticipated completion date of August 31, 2023. C-Path has previously supported the FDA's...

This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Experimental Pathology Laboratories, Inc. (EPL), a for-profit, employee-owned contract research organization based in Sterling, Virginia. The $403,303.54 contract is for pathology support services and does not have a set-aside designation. EPL has established itself as a critical research partner for various federal agencies, providing specialized technical capabilities in histology, pathology, and...

This federal contract award, valued at $28,290.26, was issued by the U.S. Environmental Protection Agency's Office of Research and Development to Experimental Pathology Laboratories, Inc. (EPL), a for-profit Subchapter S corporation specializing in toxicology pathology services. The contract is for analysis and reporting of histology and pathology of rodent tissues following exposure to per- and polyfluoroalkyl substances (PFAS) in multiple samples of adult livers and kidneys, as well as pop...